A recent GWAS on non-alcoholic fatty liver and steatohepatitis by Anstee et al.26 highlighted the role of PNPLA3, TM6SF2, GCKR, PYGO1, HSD17B13, and LEPR in these liver disorders. Here, TM6SF2 is linked to liver disorder.